TP53 and lung adenocarcinoma: Using cBioPortal analysis of TCGA lung adenocarcinomas, we confirmed that mutations in TP53 and STK11 tend to be mutually exclusive, whereas mutations in KEAP1 and STK11 tend to co-occur.